COVID-19 Vaccine Effectiveness in Organ Transplant Recipients

Strategic Insights -

A recent study has found that solid organ transplant (SOT) recipients are at high risk for complications from COVID-19, with vaccine breakthrough infections being common. Researchers at the University Health Network in Toronto, Canada, investigated the effectiveness of three doses of mRNA vaccine and early monoclonal antibody therapy in reducing disease severity against the Omicron variant. The study involved 300 adult organ transplant recipients, with 71 (24.1%) hospitalized, 44 (14.9%) requiring supplemental oxygen, and 13 (4.4%) dying from the infection.

Key Takeaways:

  • The study found that prior receipt of three mRNA vaccine doses was associated with a 70% reduction in the need for supplemental oxygen in SOT recipients with Omicron variant COVID-19 infection.
  • Early monoclonal antibody therapy, specifically sotrovimab, was also found to be effective in reducing disease severity, with a number needed to treat (NNT) of 6.64 to prevent one patient requiring oxygen.
  • The study concluded that both vaccination and early monoclonal antibody therapy were independently associated with significantly reduced disease severity in SOT recipients with Omicron variant COVID-19 infection.
  • Age and multiple comorbidities were identified as risk factors for oxygen requirement in SOT recipients with COVID-19.
  • The study's findings highlight the importance of vaccination and early treatment in preventing severe COVID-19 outcomes in SOT recipients.

Statistics:

  • 71 (24.1%) of SOT recipients were hospitalized due to COVID-19.
  • 44 (14.9%) of SOT recipients required supplemental oxygen.
  • 19 (6.5%) of SOT recipients were admitted to the ICU.
  • 15 (5.1%) of SOT recipients required mechanical ventilation (MV).
  • 13 (4.4%) of SOT recipients died from COVID-19.

Sources:

  • Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave. Clinical Infectious Diseases, 2022.
  • NewsRx. University Health Network Reports Findings in COVID-19 (Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave). Chemicals & Chemistry. May 6, 2022; p 20.